28/08/2024
Kanabo Group Plc
("Kanabo" or the "Company")
Director/PDMR Dealing
Kanabo Group Plc (LSE:KNB leading health tech company, is pleased to announces that Ian Mattioli, Non Executive Director and Chairperson, has purchased 150,000 ordinary shares at a price of £0.0123. Following the share purchase, Ian Mattioli's beneficial interests in the capital of the Company is 2.85%.
In addition, Suleman Sacranie, chief Technology Officer and founder of the GP Service, has purchased 75,187 ordinary shares at a price of £0.0133. Following the purchase of shares Suleman Sacranie holds 11,420,861 ordinary shares representing 1.81% of the issued share capital of the Company.
The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
--ENDS-
For further information, please visit http://www.kanabogroup.com/ or contact the following:
| Kanabo Group Plc | via Peterhouse Capital Tel: +44 (0)20 7469 0930 |
| Avihu Tamir, CEO | |
| Peterhouse Capital Ltd (Financial Adviser & Broker) | Tel: +44 (0)20 7469 0930 |
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Ian Mattioli
| |||
| 2
| Reason for the notification Purchase of shares | ||||
| a)
| Position/status
| PDMR | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
| ||||
| a)
| Name
| Kanabo Group Plc | |||
| b)
| LEI
| 213800XPJFSNWJIYKN52 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 2.5 pence each in Kanabo Group Plc | |||
| | | ||||
| Identification code | GB00BYQCS703 | ||||
| | | ||||
| b)
| Nature of the transaction
| Purchase of shares | |||
| c)
| Price(s) and volume(s) | | | | |
| | | Price(s) | Volume(s) | | |
| | | 1.23p | 150,000 | | |
| | | | | | |
| d)
| Aggregated information | | |||
| | | ||||
| - Aggregated volume | 18,011,111.00 | ||||
| | | ||||
| - Price | 1.25p | ||||
| | | ||||
| e)
| Date of the transaction
| 27.08.2024 | |||
| f)
| Place of the transaction
| London Stock Exchange (XLON) | |||
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
| a)
| Name
| Suleman Sacranie
| |||
| 2
| Reason for the notification Purchase of shares | ||||
| a)
| Position/status
| PDMR | |||
| b)
| Initial notification /Amendment
| Initial notification | |||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor
| ||||
| a)
| Name
| Kanabo Group Plc | |||
| b)
| LEI
| 213800XPJFSNWJIYKN52 | |||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
| a)
| Description of the financial instrument, type of instrument | Ordinary Shares of 2.5 pence each in Kanabo Group Plc | |||
| | | ||||
| Identification code | GB00BYQCS703 | ||||
| | | ||||
| b)
| Nature of the transaction
| Purchase of shares | |||
| c)
| Price(s) and volume(s) | | | | |
| | | Price(s) | Volume(s) | | |
| | | 1.33p | 75,187 | | |
| | | | | | |
| d)
| Aggregated information | | |||
| | | ||||
| - Aggregated volume | 11,420,861.00 | ||||
| | | ||||
| - Price | 1.25p | ||||
| | | ||||
| e)
| Date of the transaction
| 27.08.2024 | |||
| f)
| Place of the transaction
| London Stock Exchange (XLON) | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.